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Abstract
Background—High rates of upper and lower airways disease have occurred in Fire Department 
of the City of New York (FDNY) workers exposed to the World Trade Center (WTC) disaster site. 
Most experienced acute declines in pulmonary function, and some continued to experience decline 
over 14 years of follow-up. Similarly, some with rhinosinusitis had symptoms requiring sinus 
surgery.
Aim—To increase generalizability of biomarker investigation, we describe biomarkers of risk for 
upper and lower airway injury that do not require stored serum.
Methods—We review WTC biomarker literature.
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Results—Cytokines expressed in stored serum from the first 6 months post-9/11 can identify 
individuals at higher risk for future abnormal pulmonary function.
Conclusion—This research will help identify individuals at high risk of lung and sinus disease 
that develop after these, or future, irritant exposures for intensive monitoring and treatment. It may 
also identify targets for effective therapeutic interventions.
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The collapse of the WTC produced a massive dust cloud containing alkaline particles that 
overwhelmed the upper and lower respiratory systems defenses. Those who were present at 
the time of the collapse were caught in a dense dust cloud and sustained the highest 
exposures leading to more loss of lung function and a greater need for subspecialty 
pulmonary evaluation [Aldrich et al., 2010; Weiden et al., 2010]. Fires burned for months 
and rescue/recovery work re-suspended the dust producing lower level airway injury. In the 
14.5 years since the exposure, a subgroup of those exposed have experienced recurrent 
inflammation at the mucosal surfaces in the nose, sinuses, and lungs, producing chronic 
rhinosinusitis, declining forced expiratory volume at one second (FEV1) and reactive airway 
disease. While the first cases of disabling lower airway injury presented within weeks of 
9/11/2001, it took many years for the extent of upper airway injury to emerge, such as 
chronic sinusitis requiring treatment with sinus surgery [Niles et al., 2013, 2014; Kwon et 
al., 2016; Weakley et al., 2016]. The combined effects of upper and has resulted in chronic, 
persistent symptoms and negative impacts on quality of life, in spite of optimal medical 
management [Weakley et al., 2011; Webber et al., 2011; Wisnivesky et al., 2011; Yip et al., 
2015].
Initially, World Trade Center Cough was recognized as an acute syndrome of severe cough 
and shortness of breath leading to medical leave for 4 or more weeks [Prezant et al., 2002]. 
This was followed by an acute decline in lung function without recovery in a majority of the 
population [Aldrich et al., 2010]. Of those exposed most stabilized, however, 19.5% of the 
cohort experienced greater than 64 ml per year FEV1 decline which was twice the average 
age-related FEV1 decline of 32 ml/year [Aldrich et al., 2016]. Approximately 13% of the 
population had FEV1 below the lower limit of normal post exposure [Aldrich et al., 2010]. 
Incident respiratory disability has persisted for many years following exposures lasting only 
days to months [Niles et al., 2011], suggesting that a relatively brief but intense irritant 
exposure has produced non-resolving inflammation with consequent respiratory symptoms 
and loss of lung function.
Extensive investigations of leukocyte derived inflammatory proteins as biomarkers of lung 
injury after WTC-exposure have been reviewed elsewhere [Nolan et al., 2012; Weiden et al., 
2013]. Our group has identified biomarkers of inflammation, metabolic derangement, 
protease/antiprotease balance, and vascular injury expressed in serum within 6 months of 
WTC-exposure that were predictive of susceptibility and resistance to lung function decline 
post-WTC exposure (Table I). The initial series of investigations used serum collected 
during the evolution of disease before disability existed and lung disease was diagnosed. 
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Thus, the results were not confounded by reverse causation where the disease produced 
alteration of the biomarker. The biomarkers, therefore, are more likely to reflect 
inflammatory processes that participated in altered airway function. Confirmation of a causal 
role in disease development, however, requires experiments in model systems or effective 
treatments directed at specific pathways identified by biomarkers in specific individuals.
The assays on inflammatory cytokines, however, are not commercially available and quite 
expensive, thereby limiting generalizability for use after this or future disasters. Another 
challenge of using cytokines as biomarkers is that venipunctures need to be carefully drawn 
because leukocytes in the blood can produce inflammatory proteins post-venipuncture, 
leading to false-positive results. In consideration of these challenges, this review describes 
our data on biomarkers of risk for upper and lower airway injury, concentrating on those 
studies that do not require stored serum.
A majority of the biomarker investigation on WTC-exposed firefighters has used FEV1 
falling below the lower limit of normal as the outcome. This is a widely used measure of 
poor outcome but is confounded by pre-exposure FEV1. Those who had abnormal FEV1 
post 9/11 had below average but normal pre-9/11 FEV1 [Weiden et al., 2013]. One 
interpretation of this observation is in the subgroup with pre-exposure FEV1 close to LLN, 
an injury that resulted in a fix proportion loss FEV1 would be more likely to produce an 
abnormal FEV1. Similarly, early lung function is important for interpreting lung function 
trajectories in chronic obstructive pulmonary disease cohorts [Lange et al., 2015]. Since pre-
exposure PFT are not available on non-FDNY cohorts, the interpretation of post-exposure 
lung function can be difficult in other WTC-exposed cohorts. Additional information on the 
intrinsic risk factors, which do not depend on pre-9/11 data, of the patients for irritant 
induced upper and lower airways disease would be helpful in risk stratifying these patients.
The FDNY WTC Health Program is a resource for understanding occupational irritant-
induced airways diseases related to smoke and particulate exposures after other irritant 
exposures among additional cohorts, such as, soldiers deployed to Iraq and Afghanistan 
[Caplan-Shaw et al., 2011; King et al., 2011]. Since irritants induce an innate immune 
response that is not initially antigen specific, the biomarker pathways identified by these 
investigations may be generalizable and valuable for further study. Acute and chronic WTC 
exposure occurred and produced non-resolving upper and lower airway inflammation [Kwon 
et al., 2016]. In future disasters, improved respiratory protection during the rescue/recovery 
phase may be effective in reducing the chronic recurrent component of the irritant exposure, 
but exposures will undoubtedly occur. Our current model asserts that irritant exposures 
induced and/or sustained this pathway to non-resolving inflammation. The patients with 
poor outcome likely will have patient intrinsic characteristics that predispose them to 
exaggerated inflammation and/or poor healing. Biomarker studies will hopefully allow us to 
specifically identify at-risk patients, as well as provide additional screening and earlier 
intervention at a stage of evolution when therapy will be more effective.
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α1-ANTITRYPSIN
The identification of latent risk factors is important for disease prevention and early 
intervention strategies for WTC-related exposure. One example of a patient intrinsic latent 
risk factor for WTC-related respiratory injury is mild to moderate α1-Antitrypsin (AAT) 
deficiency. AAT is a protease inhibitor that targets neutrophil elastase, a serine protease that 
neutrophils deploy to before traveling through the collagen in basement membranes as they 
migrate from the blood stream into the alveolar space. AAT covalently binds and 
permanently inactivates neutrophil elastase. The protease inhibitor (Pi) M allele is the most 
frequent and those with PiM homozygosity have normal AAT levels and function. The PiZ 
allele carries an AAT mutation that in homozygous individuals produces severe deficiency 
leading to emphysema and airway reactivity [Kohnlein and Welte 2008]. Individuals 
carrying PiZ allele heterozygosity have moderate genetic deficiency, while those with PiS 
homozygosity or PiS heterozygosity without concomitant PiZ heterozygosity have mild 
deficiency. These mild and moderate AAT genetic deficiencies can produce reduced AAT 
levels ≤20 μmol/L [Banauch et al., 2010]. Individuals with AAT heterozygosity have 
increased risk for smoking related lung function decline [Molloy et al., 2014].
In a longitudinal study of WTC-exposed firefighters with mild and moderate AAT 
deficiency, pre-WTC exposure lung function and FEV1 change over time was normal 
[Banauch et al., 2010]. After WTC exposure, however, lung function decline was related to 
AAT genotype or AAT serum level. Those with normal AAT genes (79/90, 88%) and serum 
AAT concentration (77/90, 86%) lost 37 ml/year of FEV1. Alternately, mild AAT genetic 
abnormality (7/90,8%) lost 69 ml/year and moderate AAT genetic abnormality (4/90, 3%) 
lost 147 ml/year. Similarly, those with reduced serum AAT levels (13/90, 14%) had 86 ml/
year FEV1 decline. Mild to moderate AAT genetic abnormality is a latent risk factor that can 
be identified by genetic testing at any time before or after exposure. Functionally, the at-risk 
population can be identified by defining those with serum AAT levels ≤20 μmol/L.
Those with mild to moderate AAT deficiency have a latent risk. Importantly, it was only 
after exposure to irritants at the WTC collapse that the negative potential of this latent risk 
was revealed. WTC-exposed firefighters with reduced AAT levels or carrying PiZ or PiS 
alleles had FEV1 decline greater than 64 ml/year. Since 8.8% of the American population 
are heterozygous carriers with mild to moderate AAT deficiency [de Serres et al., 2003], this 
genetic risk will account for a large proportion of the 19.5% of the cohort that experienced 
greater than 64 ml per year FEV1 decline in the FDNY [Aldrich et al., 2016] and other 
WTC-exposed populations. Further investigation is needed to confirm the sensitivity and 
specificity of serum AAT concentration as a screening test for accelerated FEV1 decline risk. 
If these initial observations are confirmed, screening of individuals post-exposure may 
identify at risk individuals who warrant close observation and early intervention.
The AAT neutrophil axis is a well-defined component of the innate immune response. Our 
observations that reduced AAT levels increased the risk for FEV1 decline after an irritant 
exposure supports the current understanding of irritant induced lung injury.
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IgE
There is increasing data that IgE and eosinophils are biomarkers of innate immune injury to 
the upper and lower airway in WTC exposed firefighters. IgE and eosinophils are well 
defined biomarkers of allergy produced by the Th2 response [Stone et al. 2010]. IgE is an 
antibody that binds to basophils and mast cells, thereby activating them and causing airway 
constriction when bonded to antigens. Anti-IgE therapy is an effectively and widely used 
therapy for atopic asthma demonstrating that IgE is on the causal pathway for allergic 
asthma. The role of IgE in the innate immune response is poorly defined.
In addition to accelerated FEV1 decline, development of airflow obstruction defined by a 
low FEV1/FVC ratio is a well-defined adverse pulmonary outcome in occupational cohorts 
[Mohner et al., 2013]. In the first few months post-WTC-exposure, both FEV1 and FVC 
dropped to similar extents thereby preserving the FEV1/VC ratio and producing a “pseudo 
restrictive” pattern on pulmonary function testing (Table IIA). When WTC-exposed 
firefighters became sufficiently symptomatic to present for subspecialty pulmonary 
evaluation, the FEV1/FVC ratio had dropped in many individuals who also manifested 
symptoms of overt airflow obstruction [Weiden et al., 2010]. In a nested case control study 
of never-smokers, serum IgE within 6 months post-9/11 predicted abnormal FEV1/FVC ratio 
in the following 7.5 years [Cho et al., 2013]. Each 100 IU/ml increase in IgE increased the 
odds of abnormal FEV1/FVC ratio by 38%. Importantly, these patients’ pre-exposure lung 
function was normal and their IgE was in the normal range in a vast majority of the cohort 
(Table IIB). Only 4% had IgE levels greater than 500 IU/ml. There was no association 
between IgE concentration in the 6 months post-9/11 and FEV1/FVC ratio measured at the 
time the serum was drawn(Table IIC). By the time this group of symptomatic never-smokers 
presented for subspecialty pulmonary evaluation, there was a significant association between 
IgE concentration and FEV1/FVC ratio measured at that time (Table IID). Each doubling of 
IgE was associated with a reduction of 0.7 ± 0.24% FEV1/FVC ratio. This demonstrates IgE 
predicts both abnormal FEV1/FVC ratio as a dichotomous variable and FEV1/FVC ratio as a 
continuous variable. FEV1/FVC ratio was not associated with Th2 cytokinesIL-4, IL-5 or 
IL-13 (Spearman’s rho =−0.076, P =0.206; rho =−0.069, P =0.246; and rho =−0.031, P 
=0.606, respectively). This suggests that this group with irritant-induced airways disease had 
no evidence of atopic disease in spite of the association between IgE and FEV1/FVC ratio.
Since IgE is a risk factor for development of irritant-induced airflow obstruction, it is 
possible that IgE is related to the pathogenesis of lung injury. IgE is a widely used serum 
biomarker for atopy. It is on the causal pathway to asthma and atopic dermatitis since 
antibodies to IgE are effective treatment for these diseases [Milgrom et al., 1999]. Further 
work is required to better define if IgE is a causal biomarker of irritant-induced lung injury.
EOSINOPHILS
The concentrations of blood leukocytes, such as eosinophils, are stable post-venipuncture 
and easily obtained via commercially available, inexpensive cell blood counts. A study of 
1,517 non-FDNY WTC-exposed patients from the World Trade Center Environmental 
Health Center/Survivors Health Program assessed the association between blood eosinophils 
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and symptoms of asthma or obstructive airways physiology. The study cohort had no 
pre-9/11 asthma or other respiratory symptoms, had less than 5 pack years of smoking 
history, and no current smoking. Blood eosinophil differential greater than 4% of total 
leukocytes or greater than 500 cells per microliter was associated with increased wheezing. 
Elevated blood eosinophil on cell differential increased the odds of abnormal FEV1/FVC 
ratio by 2.4-fold (P <0.002) [Kazeros et al., 2013]. In a cross-sectional study of 148 patients 
who presented to the WTC Environmental Health Center/Survivors Health Program, and 
were ≤18 years old on September 11, 2001, residence in home at least 1 day in the period 
September 11–18, 2001 was associated with a 65 cell/ml increase in eosinophil 
concentration (P =0.027) and a 1.4% increase in the proportion of eosinophil on blood 
leukocyte differential (P =0.007) [Trasande et al., 2013]. In these studies, other biomarkers 
of atopy were not available so it was not possible to exclude the possibility of enhanced Th2 
responses producing the eosinophilia.
Chronic rhinosinusitis can be caused by infections, allergy, irritant exposure, and sinus 
polyps, and interactions with bacteria and irritants worsen chronic rhinosinusitis [Akdis et 
al., 2013]. As the prevalence of chronic rhinosinusitis has increased among WTC-exposed 
rescue/recovery workers [Weakley et al., 2011], the cost of caring for those with this disease 
has vastly increased [Niles et al., 2014]. In a small cross-sectional study of FDNY 
firefighters, increasing eosinophil concentration increased the odds for sinus polyps, a strong 
predictor of sinus surgery [Cho et al., 2014]. We then conducted a study of 8,227 firefighters 
with WTC-exposure between 9/11/2001 (9/11) and 9/25/2001. One of the aims of this study 
investigated the association between eosinophil concentration measured between 9/11 and 
3/10/2003 and sinus surgery [Kwon et al., 2016]. This study used sinus surgery as its 
outcome since this was a manifestation of disease with non-resolving inflammation where 
symptoms remained uncontrolled despite medical management. This longitudinal 
investigation enabled a more complete assessment of the association between elevated 
eosinophils and non-resolving upper airway inflammation.
High rates of incident sinus surgery have persisted for over a decade following WTC-
exposure, maintaining the relationship between exposure intensity and upper airways disease 
rates [Kwon et al., 2016]. Arrival at the WTC site on 9/11 or 9/12/2001 increased the risk of 
sinus surgery by 43% when compared with arriving on or after 9/13/2001. Working 6 or 
more months at the WTC-site increased the risk of sinus surgery by 48% when compared 
with working up to 1 month. Increased surgery risk was associated with increasing blood 
eosinophil counts controlling for WTC exposure. Each 100 cells/ul was associated with a 
12% increase in the risk of sinus surgery. Further those with eosinophils in the top 25% of 
the distribution, greater than or equal to 240 cells/μl had a 45% greater risk of sinus surgery 
compared with those with eosinophils below 240 cells/μl [Kwon et al., 2016]. Firefighters 
who had sinus surgery had higher blood eosinophil levels than the study cohort throughout 
the study period, including pre-9/11 levels (Fig. 1). This suggests that an elevated eosinophil 
set-point is intrinsic to this vulnerable group. Importantly, increasing eosinophils served as a 
biomarker for a population that had increased vulnerability to upper airway injury after 
WTC-exposure. There are immunological differences between those who proceed to sinus 
surgery and the rest of the cohort manifest by elevated eosinophil concentration, albeit 
within the normal range, that were evident years before disease presentation.
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Since both acute and chronic exposures to the WTC-site were significant risk factors for 
surgical treatment of chronic rhinosinusitis, there is a need for usable and effective 
respiratory protection during long-term rescue or recovery work at future disasters. As this is 
often difficult to achieve, blood eosinophils obtained before or immediately post-exposure 
could identify those who might benefit the most from early monitoring and targeted 
treatment. Blood eosinophil concentration is a widely available, well-studied biomarker of 
upper and lower respiratory disease that is inexpensive, externally valid and currently 
collected in many longitudinal cohorts.
WTC-exposure intensity, defined by arrival time, was associated with physician-diagnosed 
obstructive airways disease until September 2008 [Hall et al., 2015]. After the first 7 years, 
WTC-exposure intensity was no longer associated with incident disease even though 
elevated incidence of physician diagnosed lower airways disease has persisted throughout 
the post-exposure follow-up period. Since intensity of exposure is no longer a significant 
risk, patient intrinsic risk factors that interacted with WTC-exposure independent of 
exposure intensity, are needed for current risk stratification. Future investigation should test 
if other blood leukocytes behave like eosinophils and can be used as additional biomarkers 
of risk for airway injury.
CONCLUSION
This review has described our biomarker results concentrating on three well-defined, readily 
available inflammatory factors: AAT, IgE, and Eosinophils. The protease/anti-protease 
imbalance defined by mild to moderate genetic deficiency of ATT and the elevated set-point 
of eosinophils observed in those with non-resolving sinus inflammation are intrinsic 
characteristics of patients that can be assessed post-exposure, even currently, and, therefore, 
do not require stored serum drawn prior to or shortly after the exposure. Further longitudinal 
assessment of IgE levels is required to test if IgE concentration is also an identifier of 
intrinsic populations without characteristics of patients that has predictive validity in the 
current era. As the association between exposure and disease weakens, these and other 
biomarkers of risk for innate immune injury will become important for risk stratification of 
WTC-exposed FDNY rescue/recovery workers. The findings that elevated eosinophils are 
associated with respiratory disease in WTC Environmental Health Center/Survivors Health 
Program suggest that future research may also demonstrate that AAT and IgE will also be 
useful in other WTC-exposed populations. Predicting future risk of airway injury after 
particulate exposures can focus monitoring and early treatment on a subset of patients in 
greatest need of these services.
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FIGURE 1. 
Blood eosinophil concentration in firefighters who worked at the World Trade Center site 
during the First 2 Weeks after 9/11 is associated with sinus surgery. The graph is from Kwon 
et al. [2016] and represents the median eosinophil concentrations from March 10, 2000 to 
March 10, 2015, in 18-month intervals. The blue dots show data for Fire Department of New 
York City Firefighters who worked at the World Trade Center site during the first 2 weeks 
after the attack of September 11, 2001 (9/11) and who had eosinophil measurement between 
September 11, 2001 and March 10, 2003. The red triangles show data from the group who 
had surgical treatment for CRS by the end of the study. The number of measurements 
contributing to the values in each interval are shown below each data point. The top row of 
values show in red represents the number of eosinophil measurements in the surgical-CRS 
group. The bottom row of values show in blue represents the number of eosinophil 
measurements in the study cohort.
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TABLE I
Biomarkers Associated With Susceptibility and Resistance to Lung Function Decline Post-WTC Exposure
Susceptibility Resistance
Inflammation GM-CSF, MDC Chitotriosidase
Metabolic Leptin, dyslipidemia, glucose Amylin
syndrome intolerance
Vascular injury Apo All, Apo Al, CRP, sRAGE, LPA, PA/A sVCAM, MIP-4, MPO
Protease/antiprotease AAT, MMP-1, MMP-7, MMP-9, MMP-2, MMP-3, MMP-12, TIMP-1
AAT, Alpha-1antitrypsin; APO, apolipoprotein; Dyslipidemia, high density lipoprotein (HDL) <40 mg/dl and triglycerides ≥150 mg/dl; GM-CSF, 
granulocyte macrophage-colony stimulating factor; glucose intolerance, fasting glucose >100 mg/dl; HDL, high density lipoprotein; LPA, 
lysophosphatidic acid; MDC, macrophage derived chemokine; MIP, macrophage inflammatory protein; MMP, matrix metalloproteinases; MPO, 
myeoloperoxidase; PA/A, pulmonary artery/aorta; sVCAM, soluble vascular cell adhesion molecule; sRAGE, soluble receptor for advanced 
glycation end-products; TIMP, tissue inhibitors of matrix metalloproteinases.
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TABLE II
Blood IgE Concentration Obtained Within 6 Months of 9/11/2001in Never Smoking Firefighters Who Worked 
at the World Trade Center Site During the First 2 Weeks after 9/11Predicts Subsequent Airflow Obstruction 
Defined by Abnormal FEV1/FVC Ratio
Panel A: Longitudinal FEV1/FVC ratio, N = 282
Percentile Pre-9/11 10/2001–3/2002 Subspecialty pulmonary evaluation
25 80.8 79.9 72.4
50 84.6 84 77.3
75 88.2 87.3 81.8
Panel B: Serum IgE 10/2001–3/2002, N = 279
Percentile IgE IU/ml
10 6.18
20 12.92
30 20.81
40 31.98
50 42.06
60 62.45
70 88.43
80 150.21
90 284.77
Panel C: Association between IgE10/2001–3/2002 and FEV1/FVC 10/2001–3/2002
B Std. error P-value
Doubling IgE −0.206 0.183 0.263
Panel D: Association between IgE10/2001–3/2002 and FEV1/FVC at subspecialty pulmonary evaluation
B Std. error P-value
Doubling IgE −0.722 0.236 0.002
Presented is a reanalysis of IgE and pulmonary function data presented in Cho et al., 2013. Panel A: Longitudinal FEV1/VC ratio demonstrates 
normal pre-9/11 values. There was little change in the 6 months post-9/11but a large decline at the time of subspecialty pulmonary evaluation prior 
to 3/2008. Panel B: Distribution of IgE levels in the 6 months post-9/11 demonstrates a vast majority of the study cohort have IgE in the normal 
range. Panel C: There is no association between FEV1/FVC ratio within 6 months of 9/11/2001 and IgE drawn at the time of pulmonary function 
test. Panel D: There is a significant association between FEV1/FVC ratio at the time of subspecialty pulmonary evaluation and IgE within 6 months 
of 9/11/2001.
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